Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA PANACEA BIOTECH JUBILANT PHARMOVA /
PANACEA BIOTECH
 
P/E (TTM) x -2,647.7 -60.9 - View Chart
P/BV x 1.7 0.9 190.6% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 JUBILANT PHARMOVA    PANACEA BIOTECH
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
PANACEA BIOTECH
Mar-23
JUBILANT PHARMOVA /
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs496191 259.0%   
Low Rs269107 250.9%   
Sales per share (Unadj.) Rs394.475.1 525.2%  
Earnings per share (Unadj.) Rs-4.1-5.5 73.9%  
Cash flow per share (Unadj.) Rs30.70.9 3,497.5%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs338.6137.7 245.8%  
Shares outstanding (eoy) m159.2861.25 260.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.02.0 48.8%   
Avg P/E ratio x-93.8-27.1 346.3%  
P/CF ratio (eoy) x12.4170.0 7.3%  
Price / Book Value ratio x1.11.1 104.2%  
Dividend payout %-122.70-   
Avg Mkt Cap Rs m60,8739,142 665.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,6601,265 1,712.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,8174,599 1,365.8%  
Other income Rs m383517 74.2%   
Total revenues Rs m63,2015,116 1,235.3%   
Gross profit Rs m7,31747 15,561.0%  
Depreciation Rs m5,540391 1,416.1%   
Interest Rs m1,88244 4,241.5%   
Profit before tax Rs m278128 217.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m927466 199.1%   
Profit after tax Rs m-649-337 192.3%  
Gross profit margin %11.61.0 1,139.4%  
Effective tax rate %333.5363.5 91.8%   
Net profit margin %-1.0-7.3 14.1%  
BALANCE SHEET DATA
Current assets Rs m37,6245,623 669.1%   
Current liabilities Rs m17,7243,297 537.5%   
Net working cap to sales %31.750.6 62.6%  
Current ratio x2.11.7 124.5%  
Inventory Days Days2559 41.8%  
Debtors Days Days5648 117.1%  
Net fixed assets Rs m71,6687,028 1,019.7%   
Share capital Rs m15961 259.7%   
"Free" reserves Rs m53,7728,375 642.1%   
Net worth Rs m53,9318,436 639.3%   
Long term debt Rs m31,104202 15,425.3%   
Total assets Rs m109,29212,712 859.8%  
Interest coverage x1.13.9 29.5%   
Debt to equity ratio x0.60 2,412.9%  
Sales to assets ratio x0.60.4 158.8%   
Return on assets %1.1-2.3 -48.9%  
Return on equity %-1.2-4.0 30.1%  
Return on capital %2.52.0 127.2%  
Exports to sales %043.3 0.0%   
Imports to sales %4.124.4 16.7%   
Exports (fob) Rs mNA1,992 0.0%   
Imports (cif) Rs m2,5641,124 228.2%   
Fx inflow Rs m7,1001,992 356.4%   
Fx outflow Rs m2,5641,191 215.3%   
Net fx Rs m4,536801 566.0%   
CASH FLOW
From Operations Rs m6,607-4,225 -156.4%  
From Investments Rs m-5,4444,303 -126.5%  
From Financial Activity Rs m-1,567-184 852.8%  
Net Cashflow Rs m301-105 -286.7%  

Share Holding

Indian Promoters % 47.4 73.6 64.4%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 1.0 2,440.0%  
FIIs % 20.3 0.3 7,803.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 26.4 186.7%  
Shareholders   86,588 47,091 183.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Jubilant Pharmova vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Panacea Biotech Share Price Performance

Period Jubilant Pharmova Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.54% -1.74% 1.18%
1-Month 2.20% -20.01% -0.75%
1-Year 109.28% 11.75% 61.82%
3-Year CAGR -6.79% -12.26% 18.16%
5-Year CAGR -2.78% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.